Net profit of Torrent Pharmaceuticals rose 30.46% to Rs 591.00 crore in the quarter ended September 2025 as against Rs 453.00 crore during the previous quarter ended September 2024. Sales rose 14.66% to Rs 3246.00 crore in the quarter ended September 2025 as against Rs 2831.00 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales3246.002831.00 15 OPM %33.3633.17 - PBDT1008.00859.00 17 PBT804.00661.00 22 NP591.00453.00 30 Powered by Capital Market - Live News

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live News

Torrent Pharmaceuticals has allotted commercial paper aggregating Rs 200 crore on 24 September 2025. Powered by Capital Market - Live News

Net profit of Torrent Pharmaceuticals rose 19.91% to Rs 548.00 crore in the quarter ended June 2025 as against Rs 457.00 crore during the previous quarter ended June 2024. Sales rose 11.12% to Rs 3128.00 crore in the quarter ended June 2025 as against Rs 2815.00 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales3128.002815.00 11 OPM %32.9932.11 - PBDT939.00853.00 10 PBT738.00656.00 13 NP548.00457.00 20 Powered by Capital Market - Live News

The Board of Torrent Pharmaceuticals at its meeting held on 28 July 2025 has approved the issuance of Unsecured / Secured Redeemable Non-Convertible Debentures / Bonds by way of private placement within the borrowing limits of the Company. Powered by Capital Market - Live News